Allterum Therapeutics, Inc., a leading innovator in oncology therapeutics, today announced it has been awarded a substantial supplemental grant from the Cancer Prevention and Research Institute of Texas (CPRIT). This funding allows Allterum to expand its clinical trial in patients with...
↧
